These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10383148)

  • 1. NG2 proteoglycan-binding peptides target tumor neovasculature.
    Burg MA; Pasqualini R; Arap W; Ruoslahti E; Stallcup WB
    Cancer Res; 1999 Jun; 59(12):2869-74. PubMed ID: 10383148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the NG2 proteoglycan enhances the growth and metastatic properties of melanoma cells.
    Burg MA; Grako KA; Stallcup WB
    J Cell Physiol; 1998 Nov; 177(2):299-312. PubMed ID: 9766527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NG2 proteoglycan as a pericyte target for anticancer therapy by tumor vessel infarction with retargeted tissue factor.
    Brand C; Schliemann C; Ring J; Kessler T; Bäumer S; Angenendt L; Mantke V; Ross R; Hintelmann H; Spieker T; Wardelmann E; Mesters RM; Berdel WE; Schwöppe C
    Oncotarget; 2016 Feb; 7(6):6774-89. PubMed ID: 26735180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NG2 chondroitin sulfate proteoglycan: a multifunctional proteoglycan associated with immature cells.
    Levine JM; Nishiyama A
    Perspect Dev Neurobiol; 1996; 3(4):245-59. PubMed ID: 9117258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting bladder tumor cells in vivo and in the urine with a peptide identified by phage display.
    Lee SM; Lee EJ; Hong HY; Kwon MK; Kwon TH; Choi JY; Park RW; Kwon TG; Yoo ES; Yoon GS; Kim IS; Ruoslahti E; Lee BH
    Mol Cancer Res; 2007 Jan; 5(1):11-9. PubMed ID: 17259343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting of tumor blood vessels: a phage-displayed tumor-homing peptide specifically binds to matrix metalloproteinase-2-processed collagen IV and blocks angiogenesis in vivo.
    Mueller J; Gaertner FC; Blechert B; Janssen KP; Essler M
    Mol Cancer Res; 2009 Jul; 7(7):1078-85. PubMed ID: 19584266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A central segment of the NG2 proteoglycan is critical for the ability of glioma cells to bind and migrate toward type VI collagen.
    Burg MA; Nishiyama A; Stallcup WB
    Exp Cell Res; 1997 Aug; 235(1):254-64. PubMed ID: 9281375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NG2 proteoglycan mediates beta1 integrin-independent cell adhesion and spreading on collagen VI.
    Tillet E; Gential B; Garrone R; Stallcup WB
    J Cell Biochem; 2002; 86(4):726-36. PubMed ID: 12210739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NG2 expression regulates vascular morphology and function in human brain tumours.
    Brekke C; Lundervold A; Enger PØ; Brekken C; Stålsett E; Pedersen TB; Haraldseth O; Krüger PG; Bjerkvig R; Chekenya M
    Neuroimage; 2006 Feb; 29(3):965-76. PubMed ID: 16253523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new phage-display tumor-homing peptide fused to antiangiogenic peptide generates a novel bioactive molecule with antimelanoma activity.
    Matsuo AL; Juliano MA; Figueiredo CR; Batista WL; Tanaka AS; Travassos LR
    Mol Cancer Res; 2011 Nov; 9(11):1471-8. PubMed ID: 21900362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional and morphological effects of NG2 proteoglycan deletion on hippocampal neurogenesis.
    Thallmair M; Ray J; Stallcup WB; Gage FH
    Exp Neurol; 2006 Nov; 202(1):167-78. PubMed ID: 16814771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis of interaction between NG2 proteoglycan and galectin-3.
    Wen Y; Makagiansar IT; Fukushi J; Liu FT; Fukuda MN; Stallcup WB
    J Cell Biochem; 2006 May; 98(1):115-27. PubMed ID: 16365873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NG2/HMP proteoglycan as a cancer therapeutic target.
    Chekenya M; Immervoll H
    Methods Mol Biol; 2007; 361():93-117. PubMed ID: 17172708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of expression of the chondroitin sulphate proteoglycan neuron-glial antigen 2 on candidate stem cell populations in paediatric acute myeloid leukaemia/abn(11q23) and acute lymphoblastic leukaemia/t(4;11).
    Neudenberger J; Hotfilder M; Rosemann A; Langebrake C; Reinhardt D; Pieters R; Schrauder A; Schrappe M; Röttgers S; Harbott J; Vormoor J
    Br J Haematol; 2006 May; 133(3):337-44. PubMed ID: 16643437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed primary culture and clonal analysis provide evidence that NG2 proteoglycan-expressing cells after spinal cord injury are glial progenitors.
    Yoo S; Wrathall JR
    Dev Neurobiol; 2007 Jun; 67(7):860-74. PubMed ID: 17506499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cells.
    Curnis F; Arrigoni G; Sacchi A; Fischetti L; Arap W; Pasqualini R; Corti A
    Cancer Res; 2002 Feb; 62(3):867-74. PubMed ID: 11830545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NG2 proteoglycan increases mesangial cell proliferation and extracellular matrix production.
    Xiong J; Wang Y; Zhu Z; Liu J; Wang Y; Zhang C; Hammes HP; Lang F; Feng Y
    Biochem Biophys Res Commun; 2007 Oct; 361(4):960-7. PubMed ID: 17686464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NG2 proteoglycan-expressing microglia as multipotent neural progenitors in normal and pathologic brains.
    Yokoyama A; Sakamoto A; Kameda K; Imai Y; Tanaka J
    Glia; 2006 May; 53(7):754-68. PubMed ID: 16534776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of recombinant phages binding to pathological endothelial and tumor cells of rat glioblastoma by in-vivo display.
    Schluesener HJ; Xianglin T
    J Neurol Sci; 2004 Sep; 224(1-2):77-82. PubMed ID: 15450774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro targeting of NG2 antigen by 213Bi-9.2.27 alpha-immunoconjugate induces cytotoxicity in human uveal melanoma cells.
    Li Y; Wang J; Rizvi SM; Jager MJ; Conway RM; Billson FA; Allen BJ; Madigan MC
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4365-71. PubMed ID: 16303921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.